Evaluation of clinical significance of tuberculin sensitization in patients with lung cancer
Knoring, B.E.; Ariél', B.M.
Problemy Tuberkuleza 2: 26-30
1996
ISSN/ISBN: 0032-9533 PMID: 8657690 Document Number: 464849
Immunological and morphological findings were compared for 85 patients with lung cancer. Tuberculin sensitization was found to reflect the activity of antitumor immunity. The proportion humoral to cellular response to tuberculin and the intensity of these responses in lung cancer patients provide significant information on tumor histology and stage.
Document emailed within 1 workday
Related Documents
Knoring, B.E.; Arièl', B.M. 1994: Tuberculin sensitization in patients with lung cancer Voprosy Onkologii 40(7-12): 288-293Watanabe, A.; Nakai, Y.; Saito, J.; Honda, Y.; Tokue, Y.; Sugawara, S.; Numata, Y.; Kikuchi, T.; Sato, J.; Matsubara, N. 1992: Clinical significance of respiratory infections associated with lung cancer patients Nihon Kyobu Shikkan Gakkai Zasshi 30(7): 1250-1256
Hino, M.; Ogasawara, H.; Yoshii, A.; Yoneda, S.; Noguchi, Y.; Sakai, H.; Yoshida, K. 1992: Clinical significance of serum carcinoembryonic antigen in small cell lung cancer patients Nihon Kyobu Shikkan Gakkai Zasshi 30(2): 278-284
Volosevich, G.V. 1983: Effect of vitamins on sensitization of pulmonary tuberculosis patients to tuberculin Problemy Tuberkuleza 4: 35-37
Horiuchi, M.; Sato, K.; Nakarai, I.; Shinoda, A. 1990: Clinical significance of Su-polysaccharide (Su-PS) skin test in patients with primary lung cancer treated with chemotherapy and administration of OK-432, with special reference to the therapeutic effect and prognosis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(3 Pt 2): 468-474
Belen'kiĭ, M.S. 1973: Tuberculin tests in lung cancer Problemy Tuberkuleza 51(3): 42-45
Rodenhuis, S.; Slebos, R.J. 1992: Clinical significance of ras oncogene activation in human lung cancer Cancer Research 52(9 Suppl): 2665s-2669s
Gurevich, L.A. 1975: Growth rates of peripheral lung cancer and their clinical significance Vestnik Rentgenologii i Radiologii 6: 52-59
Shao, K.; Xiao, Z.-x.; Tang, H.-j.; Cheng, B.-c.; Zhang, D.-c.; Zhou, F.; Xiong, M.-h.; Mu, B.-d.; Huang, W.; Zhang, C.-y.; He, J. 2003: Transcriptional inactivation of RASSF1A in lung cancer and its clinical significance Zhonghua Yi Xue Za Zhi 83(7): 569-571
Watanabe, Y.; Shimizu, J.; Oda, M.; Yoshida, M.; Watanabe, S.; Iwa, T. 1991: Clinical significance of immunotherapy for lung cancer--present and future Nihon Geka Gakkai Zasshi 92(9): 1217-1220
Wang, J.; Liu, X.; Jiang, W. 2000: Expression of LRP, MRP and MDR1 in non-small-cell lung cancer and its clinical significance Zhonghua Zhong Liu Za Zhi 22(4): 304-307
Gui, S.-y.; Li, H.-h.; Zuo, L.; Zhou, Q.; Wu, Q.; Wang, Y. 2007: Protein and mRNA expression of osteopontin in lung cancer and clinical significance thereof Zhonghua Yi Xue Za Zhi 87(45): 3219-3223
Yoshimura, M.; Tsubota, N.; Miyamoto, Y.; Nakamura, H.; Minami, H.; Toyama, I. 1997: Genetic analysis and clinical significance of heterotopic hCGbeta production in lung cancer Nihon Kyobu Geka Gakkai 45(3): 392-393
Cunietti, E.; Locatelli, E.; Vaiani, G.; Baggio, E.; Gandini, M.C.; Gandini, R.; Fasoli, A. 1984: Significance of certain neoplastic markers in a series of patients with lung cancer Minerva Medica 75(18): 1041-1046
Qu, Y.-m.; Liao, G.-q.; Liu, P.-h.; Wang, H.-m.; Liu, L.; Li, L.-l.; Xie, G.-q. 2010: Clinical significance of expressions of tumor markers in peripheral blood in non-small cell lung cancer Zhonghua Yi Xue Za Zhi 90(28): 1958-1962
Dobrovol'skiĭ, N.M.; Medvedev, V.N.; Firsova, P.P.; Filatov, P.P.; Kosinova, M.V. 1983: Prognostic significance of the determination of carcinoembryonic antigen in the blood of patients with lung cancer Voprosy Onkologii 29(4): 57-60
1989: Diagnosis and first-line treatment of patients with lung cancer in Italian general hospitals. G.I.V.I.O. (Interdisciplinary Group for Cancer Evaluation) Tumori 75(2): 163-167
Ramsdell, J.W.; Peters, R.M.; Taylor, A.T.; Alazraki, N.P.; Tisi, G.M. 1977: Multiorgan scans for staging lung cancer. Correlation with clinical evaluation Journal of Thoracic and Cardiovascular Surgery 73(5): 653-659
Miyatake, K.; Gemba, K.; Ueoka, H.; Nishii, K.; Kiura, K.; Tabata, M.; Shibayama, T.; Takigawa, N.; Kawaraya, M.; Tanimoto, M. 2003: Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer Anticancer Research 23(3c): 2829-2836
Graziano, S.L.; Tatum, A.H.; Newman, N.B.; Oler, A.; Kohman, L.J.; Veit, L.J.; Gamble, G.P.; Coleman, M.J.; Barmada, S.; O'Lear, S. 1994: The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage i and Ii non-small cell lung cancer Cancer Research 54(11): 2908-2913